Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

endostar protein × Gynecologic × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Sarcoma 1 Gynecologic 1 Gastrointestinal 1 Dermatologic 1

Conditions

Uterine Cervical Neoplasms 1

Interventions

Paclitaxel 122 Carboplatin 104 pembrolizumab 102 Bevacizumab 79 Cisplatin 59 Specimen Handling 56 olaparib 48 Magnetic Resonance Spectroscopy 43 Nivolumab 37 Biopsy 37 Gemcitabine 34 Taxes 31 niraparib 29 Cyclophosphamide 27 Blood Specimen Collection 26 Letrozole 23 dostarlimab 22 liposomal doxorubicin 21 lenvatinib 21 Drug Therapy 21 Doxorubicin 21 atezolizumab 19 Radiotherapy 19 Immunoglobulin G 19 fludarabine 18 Topotecan 18 Docetaxel 18 Disulfides 17 Brachytherapy 17 durvalumab 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03086681 2025-07-29

ECWHCCFLACC

First Affiliated Hospital of Guangxi Medical University

Phase 2 Completed

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡